TABLE 4 Comparison of Clinical Outcome with Stage, CK20, and CD44 IR in pTa and pT1 Papillary Urothelial Neoplasia

From: Relationship of Cytokeratin 20 and CD44 Protein Expression with WHO/ISUP Grade in pTa and pT1 Papillary Urothelial Neoplasia

 

Total

Stage

CK20 IR

CD44 IR

 

pTa

pT1

negative

positive

N/Ac

Loss

 

Recurrence*

54.7% (58)

56.4%

50%

44.9%

63.2%

40%

63.6%

 P-value

 

0.559

0.06

0.18

Progression in stage**

17.3% (17)

12.1%

21.1%

15.2%

19.2%

10.5%

21.7%

 P-value

 

0.325

0.601

0.156

  1. *Data available for tumor recurrence in 106 of 120 cases.
  2. **Data available for tumor progression in stage in 98 of 120 cases.
Back to article page